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QualityAbstract Background: Upon recovery from anesthesia and during extubation, there will be
mechanical stimulation of receptors in the respiratory tract that results in both respiratory and car-
diovascular reﬂex responses. Heart rate plays a major determinant of myocardial oxygen consump-
tion and cardiac workload, so decreasing the heart rate will increase the ischemic threshold and
improve the cardiac performance.
Objective: To evaluate the effect of esmolol infusion on myocardial oxygen consumption during
extubation and quality of recovery in elderly patients undergoing general anesthesia.
Methods: Hundred adult patients ASA I & II scheduled for elective open unilateral inguinal hernia
were randomized, double-blindly into one of two parallel groups, esmolol group (E) (n= 50) and
control group (C) (n= 50). In the esmolol group, 1 mg/kg esmolol was given as bolus over 30 s then
followed by a continuous esmolol infusion of 100 lg/kg/min starting 10 min before end of surgery
till 5 min after extubation. While patients in group C received normal saline bolus of the same vol-
ume followed by a continuous normal saline infusion of the same volume per hour as group E.
Mean heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood
pressure (MBP), rate pressure product (RPP), anesthesia time, recovery time, postoperative nausea
& vomiting, number of doses of antiemetic agent and quality of extubation were recorded.
Results: The results showed that patients in the esmolol group had lower values of (RPP) after
esmolol infusion with statistically signiﬁcant difference when compared with patients in the control
136 S.A. ELokda, H.A. ElShamaagroup using unpaired t-test (P< 0.05), this will decrease oxygen consumption in esmolol group.
Also, there was statistically signiﬁcant difference between both groups regarding values of HR
(beat/min), SBP (mmHg), DBP (mmHg) and MBP (mmHg) starting 2 min after esmolol infusion
and continued till 10 min after extubation using unpaired t-test (p< 0.05). As regards PONV, there
was lower incidence in esmolol group when compared to control group using unpaired t-test with
statistically signiﬁcant difference (P< 0.05).
Conclusions: Esmolol is a safe, effective and well-tolerated drug that can be used in elderly patients
undergoing general anesthesia to reduce the myocardial oxygen consumption and improve the qual-
ity of recovery.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Upon recovery from anesthesia and during extubation, there
will be mechanical stimulation of receptors which present in
the larynx, trachea and bronchi. Stimulation of these receptors
results in both respiratory and cardiovascular reﬂex responses
[1]. Respiratory responses can be in the form of straining at
aspiration, coughing, breath holding, or laryngospasm. How-
ever, the cardiovascular responses can be in the form of tran-
sient tachycardia, transient hypertension, arrhythmias,
myocardial ischemia or infarction [2].
The hemodynamic changes can be explained by sympa-
thetic overactivity during extubation which will lead to
increased serum level of epinephrine and nor-epinephrine that
results in tachycardia and hypertension. These hemodynamic
changes can be well tolerated in healthy individuals but will
have deleterious effects in patients with coronary artery dis-
ease, hypertension and cerebrovascular diseases [3].
In elderly patients, due to change in vascular elasticity, the
hemodynamic changes associated with extubation are more
likely to be exaggerated and may lead to increase oxygen con-
sumption that results inmyocardial ischemiaandarrhythmia [4].
Myocardial ischemia occurs due to imbalance between
myocardial oxygen supply and oxygen demand. Heart rate
plays a major determinant of myocardial oxygen consumption
and cardiac workload, so decreasing the heart rate will increase
the ischemic threshold and improve the cardiac performance
[5]. Myocardial ischemia is variable throughout the entire per-
ioperative period, but it was found that postoperative myocar-
dial ischemia occurs more often than preoperative
(approximately 3:1) and intraoperative ischemia (approxi-
mately 5:1) [6].
Studies showed that postoperative myocardial ischemia can
be used as a reliable predictor for in-hospital and long-term
cardiac morbidity and mortality [7]. Because of myocardial
oxygen consumption is difﬁcult to be measured directly and
the rate pressure product (RPP) index was found to correlate
strongly with myocardial oxygen consumption, so RPP index
can be used for estimation of myocardial oxygen consumption
as it is easily measurable parameter [8].
Rate pressure product (RPP) is the product of systolic
blood pressure (SBP) by heart rate (HR) and used for observa-
tion of myocardial oxygen consumption. It increases when
myocardial oxygen requirements or consumption exceeds
myocardial oxygen supply [9].
Many pharmacological agents have been used to control the
hemodynamic changes during tracheal extubation with varyingsuccess rate such as local anesthetics, opioids, beta-blocking
agents, and calcium channel blockers [10,11]. Among all these
drugs b-adrenoceptor antagonists can be considered the only
well-established prophylaxis against myocardial ischemia that
demonstrates a reduction of patient morbidity and mortality
[12]. Esmolol is an ultra-short acting cardioselective b1-receptor
antagonist with half-life approximately 2 min and peak effect
about 6–10 min. Because of these pharmacokinetic characteris-
tics usually esmolol is used as a loading dose followed by contin-
uous infusion [13]. It has been used for prevention and treatment
of intra-operative and postoperative tachycardia and hyperten-
sion. Also, it has been reported to decrease plasma catechol-
amine levels and preventing hemodynamic changes during
intubation, laryngoscopy and extubation [14].
The goal of this study was to evaluate the effect of esmolol
infusion on myocardial oxygen consumption during extuba-
tion and quality of recovery in elderly patients undergoing gen-
eral anesthesia.
2. Patients and methods
2.1. Study groups
After getting approval from the ethical committee of Dallah
Hospital, Riyadh, Saudi Arabia, written informed consents
were taken from all patients before entry into the study. This
study was conducted on hundred (100) old adult male and
female patients American Society of Anesthesiologist (ASA)
physical status I–II, scheduled for elective open unilateral
inguinal hernia repair during the period from May 2013 to
April 2014, those patients were enrolled into one of two ran-
domized, double-blind, controlled parallel group study using
sequentially numbered, sealed, opaque envelopes.
Patients with uncontrolled systemic diseases (e.g. diabetes
mellitus, asthma and chronic obstructive lung disease), signif-
icant organ dysfunctions (e.g. cardiac, respiratory, renal or
liver disorders), morbid obese (BMI > 40), non-smokers, his-
tory of allergy to the drugs used, use of b-blockers or calcium
channel blockers, chronic use of opioids or non-steroidal anti-
inﬂammatory drugs, history of postoperative nausea & vomit-
ing (PONV) or motion sickness were excluded from the study.
Patients were randomly divided into two groups, Esmolol
group (group E n= 50) and Control group (group C
n= 50). All patients were premedicated orally with bromaze-
pam (3 mg) and ranitidine (150 mg) 1–2 h preoperatively. Ten
minutes before end of surgery till ﬁve minutes after extubation,
group E patients will receive unknown solution (A), while
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blind fashion. These solutions were prepared in the pharmacy,
have the same volumes and the anesthetist was blinded to the
grouping design.
In group E, patients received esmolol hydrochloride (Brev-
ibloc premixed, 10 mg/ml, Baxter Healthcare Corporation,
USA) 1 mg/kg as bolus dose over 30 s followed by a continu-
ous esmolol infusion of 100 lg/kg/min starting 10 min before
end of surgery till 5 min after extubation. While patients in
group C received normal saline bolus of the same volume fol-
lowed by a continuous normal saline infusion of the same vol-
ume per hour as group E.
2.1.1. Anesthetic technique
On arrival of the patient to the operating theater, all standard
monitors were applied including heart rate (HR), electrocar-
diogram (ECG), oxygen saturation (Spo2), end-tidal CO2,
arterial blood pressure (systolic (SBP), diastolic (DBP) & mean
(MAP)) and temperature. In addition to these monitors, both
neuromuscular monitoring, train of four (TOF) and bipolar
BIS electrodes (BIS QUATRO-BX13366, Aspect Medical Sys-
tems, Inc.USA) were applied to the patient. After induction of
anesthesia, arterial catheter was inserted in the radial artery for
continuous blood pressure monitoring and frequent blood gas
analysis. Initial or baseline readings of all these monitors were
taken and recorded before starting any drug infusion (base
line) in the pre-anesthetic period, then during intraoperative
period also.
Anesthesia was induced by intravenous remifentanil
(1 lg/kg) over 30–60 s, followed by propofol (1–2 mg/kg).
Intubation was performed using rocuronium bromide in a dose
of (0.6 mg/kg). Maintenance of anesthesia was carried by con-
tinuous infusion of remifentanil (0.25 lg/kg/min), sevoﬂurane
1–2% MAC and 50% air in oxygen. Anesthesia was titrated
to keep the ‘BIS’ value within the range (50–60). Muscle
relaxation was monitored by ‘TOF’ for every ten minutes,
rocuronium infusion from 0.3 to 0.6 mg/kg/hr was given and
adjusted to maintain 1–2 responses to ‘TOF’ stimulation.
Lungs were mechanically ventilated to maintain normocapnia
(Etco2 35–40 mmHg). All surgical procedures were done by
the same surgeon who was blind about the study.
All vital signs were recorded before induction of anesthesia
(preoperative), before esmolol infusion (base line for the
study), 2 min after starting infusion, before extubation, then
1, 3, 5, and 10 min after extubation. All patients were anesthe-
tized by one anesthetist who was not involved in the study and
was instructed to follow the study design. Lactated Ringer’s
solution was set at a rate of 6 ml/kg/hr as a baseline infusion
in both groups. Additional solutions were infused if required.
Neither anti-inﬂammatory drugs nor local anesthetic inﬁltra-
tion of the surgical wounds were used in both groups.
The following medications were used when needed, atro-
pine sulfate 0.5 mg was used for bradycardia (HR<
50 beats/min), ephedrine 5 mg was used for hypotension not
responding to IV ﬂuids (SBP < 30% of the base line for more
than 60 s). Increase in SBP more than 30% of the base line for
more than 60 s or HR more than 130 beats/min for longer than
60 s was managed by increasing the anesthetic depth by
increasing MAC sevoﬂurane by 1%.
At the end of surgery, all anesthetic agents were discontinued
and the patients were ventilatedwith 100%oxygen. The residual
effect of rocuronium was reversed with neostigmine in a dose of40 lg/kg and glycopyrolate 20 lg/kg. Then the patients were
extubated after regaining their spontaneous breathing and
transferred to the postanesthesia care unit for routine follow
up. Every patient was observed continuously during and after
termination of anesthesia. The quality of extubation was
assessed using a 5-point rating scale, where 1: no cough and nor-
mal breathing, 2:mild cough, 3:moderate cough, 4: severe cough
and difﬁculty in breathing, and 5: laryngospasm with severe
cough. PONV was also assessed & graded on a 5-point scale;
0: no nausea, 1: mild nausea, 2: moderate nausea, 3: severe nau-
sea and 4: retching or vomiting. Patients with PONV received
8 mg ondansetron hydrochloride IV & the total dose of antie-
metic was calculated during the ﬁrst 24 h after surgery.
2.1.2. Data for assessments
 Mean heart rate (HR) (beats/min).
 Systolic blood pressure (SBP) (mmHg).
 Diastolic blood pressure (DBP) (mmHg).
 Mean arterial blood pressure (MAP) (mmHg).
 Rate pressure product (RPP) (beats/min mmHg).
 Duration of anesthesia (in minutes); from the time of induc-
tion to withdrawal of all anesthetics.
 Recovery time (in minutes); from withdrawal of all anes-
thetics to extubation.
 PONV.
 Number of doses of antiemetic agent.
 Quality of extubation.
2.1.3. Statistical analysis
Sample size was calculated guided by the following data power
of the test 80% with beta error 20% and alpha error accepted
to be 5%. Conﬁdence level was 95%, success rate of the tech-
nique was used in special formula for calculation to be 100
totally classiﬁed 1:1. Analysis of data was done by IBM com-
puter using SPSS (statistical package for social science version
12) as follows; description of quantitative variables as mean,
SD and range then, description of qualitative variables as
number and percentage. Chi-square test was used to compare
qualitative variables between both groups. Unpaired t-test was
used to compare quantitative variables in parametric data
(SD < 50% mean) and paired t-test was used to compare
quantitative variable in the same group. P value > 0.05 is con-
sidered insigniﬁcant, P value < 0.05 is signiﬁcant, while P
value <0.001 is highly signiﬁcant (see Fig. 1).
3. Results
3.1. Demographic & operative data of patients
Analysis of the results showed that there was no signiﬁcant dif-
ference in demographic and operative data of the patients
between the two groups (Table 1).
3.2. Hemodynamics
The results of current study showed that there were no differ-
ence between esmolol and control groups regarding values of
mean heart rate (beat/min), systolic blood pressure (mmHg),
diastolic blood pressure (mmHg) and mean blood pressure
147 patients were assessed for 
eligibility of the study
47 patients were excluded due to the 
presence of one or more exclusion 
criteria (n=30) and others refused to 
participate in the study (n=17)
100 patients were 
enrolled
100 patients were 
randomized
                Group E (n=50) 
All of them received the allocated 
intervention 
                Group C (n=50) 
All of them received the allocated       
intervention 
All of them were followed up and none of 
them discontinued the intervention
All 50 patients were included in the final 
analysis and no one was excluded 
All of them were followed up and none of 
them discontinued the intervention
All 50 patients were included in the final 
analysis and no one was excluded 
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Follow-Up
Analysis
Figure 1 Flow diagram of participants in the current study.
Table 1 Demographic and operative data (mean ± SD).
Esmolol group (n= 50) Control group (n= 50) t P
Age (yr) range 55–68(60 ± 3) 57–66(62 ± 4) 0.8 0.44 NS
Sex Fisher exact 0.37
Male 44 43 NS
Female 6 7
Weight (kg) 68–88(82.6 ± 6) 67–98(85 ± 10) 0.9 0.30 NS
Height (cm) 160–179(165 ± 10) 158–178(166 ± 8) 1.1 0.27 NS
ASA (I/II) 38/12 36/14 Fisher 0.56 NS
Duration of surgery (min) 48–70(60 ± 5) 50–72(61.6 ± 8) 1.5 0.20 NS
Duration of anesthesia (min) 55–75(65.8 ± 7) 54–76(63 ± 8) 1.1 0.23 NS
Recovery time (min) 3–7(5.6 ± 1.6) 6–12(9 ± 2.5) 1.4 0.19 NS
138 S.A. ELokda, H.A. ElShamaa(mmHg) preoperatively till 2 min after esmolol infusion
(P> 0.05). However, there was statistically signiﬁcant differ-
ence between both groups regarding the same parameters
starting 2 min after esmolol infusion and continued till
10 min after extubation using unpaired t-test (p< 0.05)
(Figs. 2–5).On the other hand there was statistically signiﬁcant differ-
ence among the patients in the esmolol group regarding values
of mean heart rate (beat/min), systolic blood pressure (mmHg)
and diastolic blood pressure (mmHg) before and after esmolol
infusion (P< 0.05) using paired t-test. Meanwhile, there was
no difference regarding values of mean blood pressure
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esmolol infusion (p> 0.05) (Figs. 2–5).
3.3. Rate pressure product (RPP) and oxygen consumption
The results of this study demonstrated that patients in the
esmolol group had lower values of (RPP) after esmolol infu-
sion and continued up to 10 min after extubation with statisti-
cally signiﬁcant difference when compared with patients in the
control group using unpaired t-test (P< 0.05). Consequently,
the myocardial oxygen consumption and myocardial ischemia
will be less among those patients. On the other hand, there was
statistically signiﬁcant difference among patients in esmolol
group regarding RPP before and after esmolol infusion using
paired t-test (P< 0.05) (Fig. 6).
3.4. Quality of recovery
3.4.1. Postoperative nausea & vomiting (PONV)
The results of our study showed that there was lower incidence
of PONV among patients in esmolol group when compared to
patients in the control group using unpaired t-test withstatistically signiﬁcant difference (P< 0.05). Only 3 patients
in esmolol group (6%) who had severe nausea compared to
20 patents (40%) in the control group (Table 2). Regarding
the total number of doses of antiemetic agent, it was found
that 26 (52%) patients in the control group received 2 or more
doses compared to 11 (22%) patients in the esmolol group with
Table 2 Postoperative nausea & vomiting (number &%).
Grade Esmolol group
(n= 50)
Control group
(n= 50)
X2 P
0 (no nausea) 21(42%) 0 (0%) 6.8 0.02 S
1 (mild nausea) 18 (36%) 9 (18%)
2 (moderate nausea) 8 (16%) 15 (30%)
3 (severe nausea) 3 (6%) 20 (40%)
4 (vomiting) 0 (0%) 6 (12%)
Table 4 Extubation quality scale (number &%).
Grade Esmolol group
(n= 50)
Control group
(n= 50)
X2 P
1 23 (46%) 0 (0%) 7.4 0.002 S
2 18 (36%) 8 (16%)
3 6 (12%) 17 (34%)
4 3(6%) 19 (38%)
5 0 (0%) 6 (12%)
140 S.A. ELokda, H.A. ElShamaastatistically signiﬁcant difference (P< 0.05) using unpaired t-
test (Table 3).
3.4.2. Extubation quality
The results of current study documented that the majority of
patients in the esmolol group (41 patients = 82%) had no or
mild cough and only 9 (18%) patients had moderate to severe
cough compared to 36 (72%) patients in the control group had
moderate to severe cough while only 9 (18%) patients had mild
or no cough with statistically signiﬁcant difference (P< 0.05)
using unpaired t-test (Table 4). There are 6 (12%) in the con-
trol group had severe cough with laryngospasm while no
patients in the study group had.
4. Discussion
4.1. Hemodynamic responses and oxygen consumption;
Withdrawal of anesthetic drugs during recovery from general
anesthesia is usually associated with marked elevations in both
heart rate and arterial blood pressure before and during extu-
bation due to release of catecholamine in the circulation [15].
As result of these hemodynamic changes together with some
degree of cardiovascular disease in old patients, myocardial
ischemia due to increased myocardial oxygen consumption
can occur [16].
Rate-pressure product (RPP) index that results from multi-
plying systolic blood pressure (SBP) by heart rate (HR) can be
used as a relevant parameter in evaluating the myocardial oxy-
gen consumption and ventricular function, the higher the RPP
index the higher the possibility of myocardial ischemia [9].
Many prophylactic pharmacological measures have been used
to control the hemodynamic changes that happen during
recovery from anesthesia and extubation [17]. Among these
medications, opiate analgesics, calcium channel blockers,
nitrates, lidocaine, dexmedetomidine & esmolol [18–20]. The
pharmacokinetics of ultra-short acting, cardioselective, beta
blocker esmolol make it the drug of choice in situations with
high catecholamine levels such as emergence from general
anesthesia and during tracheal extubation [21].
The present study shows that esmolol hydrochloride
reduced HR, SBP, MAP, and RPP from starting the infusion
till after extubation. Thus, the cardiac work load will reduce
and consequently the myocardial oxygen consumption &Table 3 Total number of doses of antiemetic agent (ondansetron H
Number of doses None 1
Esmolol group (n= 50) 21(42%) 18 (36%)
Control group (n= 50) 0 (0%) 24 (48%)perioperative myocardial ischemia. This result was in agree-
ment with results of other studies. In 2013, Alkaya et al. [1]
reported that esmolol infusion in a dose of 2 mg/kg 5 min
before extubation can prevent tachycardia and hypertension
associated with extubation in patients undergoing elective
craniotomy.
In a meta-analysis of 32 randomized trials including 1765
patients Landoni et al. [22] studied if esmolol reduces the per-
ioperative ischemia in noncardiac surgery or not. They found
that use of esmolol was accompanied by great reduction in
myocardial ischemic episodes (5/283 [1.76%]) in the esmolol
group compared to (16/265 [6.03%]) in the control group with
p= 0.003. In addition, the use of esmolol was associated with
lower incidence of hypotension (17/384 [4.42%] v 38/439
[8.65%]) with p= 0.17 and bradycardia (25/342 [7.30] v
17/406 [4.18%]) with p= 0.42 when compared to control
group. Finally, they concluded that esmolol can reduce
myocardial ischemia in noncardiac surgery without causing
episodes of hypotension or bradycardia.
In a comparative study between different doses of esmolol
on the hemodynamic response due to extubation, Wang
et al. [23] found that 1.5 mg/kg and 2.0 mg/kg doses of esmolol
were effective in controlling both the heart rate and blood
pressure during extubation. Also, the result of this study was
in accordance with another study that was done by Singh
et al. [24] who studied the effect of esmolol on the cardiovas-
cular response during laryngoscopy & intubation and con-
cluded that esmolol in a dose of 2 mg/kg is effective in
attenuating the hemodynamic responses to laryngoscopy and
intubation without any complications such as bradycardia or
hypotension. In a study done by Dyson et al. [25] it was demon-
strated that esmolol in a dose of either 1.5 mg/kg or 2.0 mg/kg
was effective in controlling the tachycardia and hypertension
during extubation, but esmolol 1 mg/kg was ineffective.
On the other hand, this study come in contrast with another
study reported that both esmolol and lidocaine can attenuate
the hemodynamic responses to intubation but not during
extubation [26].
4.2. Quality of recovery
4.2.1. Postoperative nausea and vomiting (PONV)
The Postoperative nausea and vomiting (PONV) is considered
as one of the most commonly reported complications of gen-Cl) (number &%).
2 P3 X2 P
8 (16%) 3 (6%) 5.90 0.03 S
20 (40%) 6 (12%)
Effect of esmolol infusion on myocardial oxygen consumption 141eral anesthesia. It represents 10% in patients without any risk
factor but may reach up to 61–79% in the presence of 3 or 4
risk factors respectively [27]. Inhalational general anesthetics
and nitrous oxide have greater risk for PONV (59%) than
intravenous general anesthetics (28%). The presence of PONV
will increase the patient’s morbidity, length of hospital stay
and the overall costs [28].
The current study shows that the patients in esmolol group
have less incidence of PONV compared to the patients in the
control group and also, they received less total number of anti-
emetic agent than the control group. These results are in agree-
ment with another study done by Coloma et al. [29] who
concluded that the use of esmolol in outpatient gynecologic
procedures done under desﬂurane & remifentanil anesthesia
was associated with less incidence of PONV. Also, in 2007
Oztruk et al. [30] did another study on 40 patients undergoing
laparoscopic cholecystectomy and reported that the combina-
tion of esmolol & alfentanil was associated with less rate of
PONV.
Although there is no deﬁnite mechanism for the antiemetic
effect of esmolol, but it can be explained partly by the opioids
sparing effect & the prevention of hemodynamic instability
occurring during stress periods of anesthesia and surgery.
4.2.2. Quality of extubation
The results of this study demonstrate that use of esmolol was
accompanied by smooth recovery and good quality of extuba-
tion with low incidence of cough and laryngospasm among
these patients. Our results are in accordance with the results
of Alkaya et al. [1] who studied the effect of esmolol on hemo-
dynamic responses to tracheal extubation after craniotomy
surgeries and reported that the majority of patients in the
esmolol group had better extubation quality score when com-
pared to the patients in the control group.
4.2.3. In conclusion
From the previously mentioned data, we can conclude that
esmolol is a safe, effective and well-tolerated drug that can
be used in elderly patients undergoing general anesthesia to
reduce the myocardial oxygen consumption and improve the
quality of recovery.Conﬂict of interest
No conﬂict of interest.
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